Product Datasheet
PRDM1 Antibody
Catalog Number: 48403
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:O75626
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- Recombinant protein
- appl_detail:
- WB: 1:500-1:2,000
ICC: 1:200-1:1,000
FC: 1:100-1:200
- other_names:
- B Lymphocyte Induced Maturation Protein 1 antibody
Beta interferon gene positive regulatory domain I binding factor antibody
Beta-interferon gene positive regulatory domain I-binding factor antibody
BLIMP-1 antibody
BLIMP1 antibody
Positive Regulatory Domain I Binding Factor 1 antibody
Positive regulatory domain I-binding factor 1 antibody
PR Domain Containing 1 antibody
PR domain containing 1 with ZNF domain antibody
PR domain containing 1 with ZNF domain isoform 2 antibody
PR domain containing protein 1 antibody
PR domain zinc finger protein 1 antibody
PR domain-containing protein 1 antibody
PRDI BF1 antibody
PRDI binding factor 1 antibody
PRDI-BF1 antibody
PRDI-binding factor 1 antibody
PRDM 1 antibody
Prdm1 antibody
PRDM1_HUMAN antibody
- Purification:
- ProA affinity purified
- Applications:
- WB, ICC, FC
- Background:
- The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.
© Signalway Biotechnology All Rights Reserved.